How to Document a Diabetic Foot Ulcer for Medicare Compliance
Medicare documentation requirements for diabetic foot ulcers — wound measurements, Wagner staging, vascular assessment, offloading compliance, and the elements that prevent denials.
Damon Ebanks
Medipyxis
How Do I Document a Diabetic Foot Ulcer for Medicare?
Medicare requires that diabetic foot ulcer (DFU) documentation establish medical necessity, demonstrate clinical decision-making, and contain specific wound assessment elements defined by your MAC's Local Coverage Determination. A DFU note missing any required element -- even a clinically correct note -- will be denied on audit. The documentation standard is not "did you do the right thing" but "can a reviewer confirm you did the right thing from what you wrote."
Here are the elements every DFU encounter note must contain.
What wound assessment elements are required?
Each visit note must document:
- Anatomical wound location. Specific enough to distinguish between wounds on the same foot -- "plantar surface of right first metatarsal head" rather than "right foot." Medicare reviewers reject vague locations as insufficient to confirm wound identity across visits.
- Wound measurements. Length, width, and depth in centimeters. Measurements must use a consistent technique (longest length perpendicular to widest width). Document undermining and tunneling separately with clock-position notation (e.g., "tunneling 1.2 cm at 3 o'clock").
- Wagner grade. The Wagner classification (0-5) is the standard DFU staging system for LCD purposes. Grade 0 (pre-ulcerative lesion) through Grade 5 (extensive gangrene) must be documented at initial evaluation and updated when the wound changes classification.
- Wound bed description. Percentage of granulation tissue, slough, eschar, and epithelial tissue. This establishes whether the wound bed is progressing, stalled, or deteriorating -- and supports the treatment rationale.
- Wound edges and periwound skin. Rolled or epibolic edges, maceration, callus formation, erythema, or induration. These findings affect debridement decisions and signal complications.
- Infection assessment. Presence or absence of clinical signs -- erythema, warmth, edema, purulent drainage, odor. If infection is present, document whether it is superficial or deep, whether a culture was obtained, and the antibiotic regimen initiated.
For the complete set of wound documentation standards across all wound types, see our DFU clinical guide.
What systemic and vascular elements must be included?
DFU documentation requires systemic context that general wound notes do not:
- Vascular assessment. An Ankle-Brachial Index (ABI) or toe pressure must be documented at initial evaluation and repeated if healing stalls. Medicare considers vascular adequacy a prerequisite for coverage of advanced wound treatments -- a DFU with an ABI <0.5 and no vascular surgery referral documented will trigger denial for skin substitutes and NPWT. Document the ABI value, the date it was obtained, and the clinical interpretation.
- Glycemic status. Document the most recent HbA1c value and date. Uncontrolled diabetes (A1c >9%) without a documented glycemic management plan undermines medical necessity for advanced treatments. The note should reference coordination with the patient's endocrinologist or primary care physician for glycemic optimization.
- Neuropathy assessment. Document sensory testing results (monofilament, tuning fork, or pinprick) and protective sensation status. Neuropathy is both an etiologic factor and a risk modifier -- its documentation supports the ICD-10 code selection (E11.621 for Type 2 diabetes with foot ulcer, plus the appropriate neuropathy code).
What offloading documentation is required?
Medicare requires documentation that offloading -- the use of devices to redistribute pressure away from the ulcer site -- has been prescribed, provided, and that the patient is compliant. This is one of the most frequently missing elements in DFU claims.
Document:
- Device prescribed. Total contact cast, removable cast walker (RCW), therapeutic shoes, or custom orthotic. Specify the product by name.
- Patient compliance. Whether the patient is wearing the device as prescribed. If the patient is non-compliant, document the counseling provided and the clinical consequence discussed.
- Offloading adequacy. Whether the current device is achieving adequate pressure redistribution based on clinical assessment.
Missing offloading documentation is the single most common reason DFU skin substitute claims are denied. A wound that is not being offloaded is not receiving "optimal standard of care," which disqualifies it from advanced treatment coverage under most LCDs.
What triggers Medicare denials for DFU claims?
Three documentation gaps cause the majority of DFU denials:
No vascular assessment. If no ABI or toe pressure is documented -- or the value is critically low with no vascular referral -- the MAC will deny advanced wound treatment claims as not medically necessary. The treatment cannot be justified without evidence of adequate perfusion to support healing.
No offloading documentation. Conservative care requirements include offloading. Without documentation that offloading was prescribed and monitored, the MAC's position is that standard care was not attempted before escalation.
No progression tracking. Medicare expects measurable wound improvement. If the wound is the same size visit after visit with no documented change in treatment approach, reviewers interpret this as either ineffective treatment without clinical reassessment or inaccurate measurements. Document the percentage of area reduction between visits and, when a wound stalls, the clinical rationale for modifying or continuing the current treatment plan.
For the LCD requirements that govern DFU coverage decisions and how to operationalize compliance, see our LCD compliance guide.